A detailed history of Park Avenue Securities LLC transactions in Vericel Corp stock. As of the latest transaction made, Park Avenue Securities LLC holds 5,099 shares of VCEL stock, worth $301,197. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,099
Holding current value
$301,197
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 14, 2025

BUY
$40.05 - $59.11 $204,214 - $301,401
5,099 New
5,099 $280,000
Q2 2024

Jul 09, 2024

SELL
$41.71 - $52.9 $4,963 - $6,295
-119 Reduced 2.36%
4,923 $226,000
Q1 2024

Apr 10, 2024

BUY
$32.52 - $52.33 $163,965 - $263,847
5,042 New
5,042 $262,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.79B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Park Avenue Securities LLC Portfolio

Follow Park Avenue Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Park Avenue Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Park Avenue Securities LLC with notifications on news.